IL6 and chronic obstructive pulmonary disease: Owing to their pivotal roles in inflammation, IL-1β and IL-6 have been proposed as biomarkers of lung injury and airway inflammation, particularly in diseases such as chronic obstructive pulmonary disease (COPD), ALI and ARDS (62).